Herbalife (HLF) EBITDA (2009 - 2026)

Herbalife has disclosed EBITDA across 18 years of filings, most recently posting $128.3 million for Q2 2026.

• In Q2 2026, EBITDA fell 3.24% year-over-year to $128.3 million; the TTM figure through Jun 2026 stood at $492.3 million (up 0.67% YoY), while the FY2025 annual figure was $481.0 million, up 24.64% from the prior year.
• EBITDA came in at $128.3 million for Q2 2026 at Herbalife, down from $138.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $155.8 million in Q2 2022 to a low of $55.8 million in Q4 2023.
• Average EBITDA over 5 years is $113.1 million, with a median of $123.1 million recorded in 2023.
• Year-over-year, EBITDA tumbled 53.95% in 2023 and jumped 90.86% in 2024.
• Over 5 years, EBITDA stood at $88.9 million in 2022, then tumbled by 37.23% to $55.8 million in 2023, then surged by 90.86% to $106.5 million in 2024, then retreated by 6.29% to $99.8 million in 2025, then climbed by 28.56% to $128.3 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $128.3 million in Q2 2026, $138.4 million in Q1 2026, and $99.8 million in Q4 2025.